Creatine kinase activity inhibitor in sera from patients with muscle disease
Open Access
- 1 February 1987
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 30 (2) , 213-217
- https://doi.org/10.1002/art.1780300212
Abstract
Sera from patients with muscle disease contain an inhibitor of creatine kinase (CK) which may lead to underestimation of CK activity. The inhibitor was dialyzable, but was not related to previously described low molecular weight inhibitors of CK. In a small group of patients with myositis, the amount of inhibitor present in serum was correlated with the severity of the illness. Our findings suggest that the CK inhibitor may be released into serum from injured muscle.This publication has 15 references indexed in Scilit:
- THE CREATINE-CREATINE PHOSPHATE ENERGY SHUTTLEAnnual Review of Biochemistry, 1985
- Molecular mechanism for the production of multiple form of MM creatine kinaseCellular and Molecular Life Sciences, 1984
- Human myocardial and skeletal muscle enzyme activities: creatine kinase and its isozyme MB as related to citrate synthase and muscle fibre typesClinical Physiology and Functional Imaging, 1983
- Isolation and identification of a new potent inhibitor of creatine kinase from human serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- The effect of dilution on creatine kinase activityClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Identification of a creatine kinase inhibitor in human serumClinical Biochemistry, 1975
- Evaluation of laboratory tests in diagnosis and management of polymyositisThe Lancet Healthy Longevity, 1972
- The significance of the dilution effect in serum creatine kinase diagnosis of muscular dystrophyClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- Effect of dilution on the activity of serum creatine phosphokinaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological seraClinica Chimica Acta; International Journal of Clinical Chemistry, 1962